Bora Pharmaceuticals

About Bora Pharmaceuticals

Founded in 2007, Bora Pharmaceuticals (“Bora” or “the Company”, 6472.TW and BORAY.OTCQX) is a leading pharmaceutical services company with a vision and goal of “Contributing to Better Health All Over the World”. We empower pharmaceutical and biotech partners to optimize product development, accelerate launches, and scale supply to meet global patient needs. At the same time, we actively broaden R&D and sales infrastructure, focusing on niche and rare disease markets to improve patients' quality of life.

  • Country/Region:
    Canada
  • On CPHI since:
    2022
  • Employees:
    500 - 999
Company types
CMO/CDMO
Contract Service
Primary activities
Contract Manufacturer
Contact info
  • 7333 Mississauga Road Mississauga, L5N 6L4, Mississauga, Canada
Meet us at

CPHI Milan 2026

Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026

Products from Bora Pharmaceuticals (1)

  • Pharmaceutical and Biological Products Contract Development and Manufacturing

    Product Pharmaceutical and Biological Products Contract Development and Manufacturing

    Bora Pharmaceuticals is a full-service global CDMO specializing in the development and manufacturing of complex oral solid, liquid, semi-solid, ophthalmic, biologics, and sterile injectable pharmaceutical products for clinical and commercial supply. Our comprehensive solutions and expansive global network ...

Bora Pharmaceuticals Resources (1)

  • News CPHI Barcelona 2023: Tackling the Pharma Talent Precipice – Part 1

    This year at CPHI Barcelona (24–26 October, 2023) we sat down with C-suite executives and HR professionals to discuss the looming talent crisis in the pharmaceutical industry. With hybrid working persisting post-pandemic and a growing skills gap, how can the pharmaceutical supply chain adjust to a changing labour force?